Stillwater, MN – According to filings with the U.S. Securities and Exchange Commission, Vascudyne is raising $17,739,865.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kemal Schankereli played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Vascudyne
Vascudyne is the worlds leading center of excellence for developing and manufacturing engineered tissue. We provide our clients with world class engineered tissue, unique engineered tissue based device designs, manufacturing capabilities, technical expertise, and product development support.

To learn more about Vascudyne, visit http://vascudyne.com/

Contact:
Kemal Schankereli, Chief Executive Officer
763-645-4609
kschankereli@vascudyne.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved